Enregistré dans:
| Auteurs principaux: | Hugo Klempfner, Paul Anderson |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.365 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
par: Arjun Pon Avudaiappan, et autres
Publié: (2024)
par: Arjun Pon Avudaiappan, et autres
Publié: (2024)
Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
par: Yin Zhou, et autres
Publié: (2024)
par: Yin Zhou, et autres
Publié: (2024)
Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
par: Sean Lim, et autres
Publié: (2026)
par: Sean Lim, et autres
Publié: (2026)
Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
par: Shugo Yajima, et autres
Publié: (2025)
par: Shugo Yajima, et autres
Publié: (2025)
Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
par: Mohammed Al‐Zubaidi, et autres
Publié: (2024)
par: Mohammed Al‐Zubaidi, et autres
Publié: (2024)
Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
par: Kylie Yen‐Yi Lim, et autres
Publié: (2025)
par: Kylie Yen‐Yi Lim, et autres
Publié: (2025)
Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
par: Serdar Turan, et autres
Publié: (2025)
par: Serdar Turan, et autres
Publié: (2025)
Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
par: Alison Hiong, et autres
Publié: (2025)
par: Alison Hiong, et autres
Publié: (2025)
Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
par: Rebecca Martin, et autres
Publié: (2025)
par: Rebecca Martin, et autres
Publié: (2025)
Patient experience of bladder cancer: A data linkage study
par: Snehadhar Shah, et autres
Publié: (2024)
par: Snehadhar Shah, et autres
Publié: (2024)
A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
par: John Lahoud, et autres
Publié: (2024)
par: John Lahoud, et autres
Publié: (2024)
Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
par: Liwu Guo, et autres
Publié: (2024)
par: Liwu Guo, et autres
Publié: (2024)
Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
par: Katherina Y. Chen, et autres
Publié: (2026)
par: Katherina Y. Chen, et autres
Publié: (2026)
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
par: Liam Mannion, et autres
Publié: (2024)
par: Liam Mannion, et autres
Publié: (2024)
Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
par: Yu Ishizuya, et autres
Publié: (2026)
par: Yu Ishizuya, et autres
Publié: (2026)
The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
par: Kunal K. Sindhu, et autres
Publié: (2024)
par: Kunal K. Sindhu, et autres
Publié: (2024)
Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
par: Rodolfo Hurle, et autres
Publié: (2025)
par: Rodolfo Hurle, et autres
Publié: (2025)
The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
par: Abel Tesfai, et autres
Publié: (2024)
par: Abel Tesfai, et autres
Publié: (2024)
Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
par: Jacob Hanna, et autres
Publié: (2026)
par: Jacob Hanna, et autres
Publié: (2026)
Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
par: Rachel Weng, et autres
Publié: (2025)
par: Rachel Weng, et autres
Publié: (2025)
Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
par: Jeremy Cheng, et autres
Publié: (2025)
par: Jeremy Cheng, et autres
Publié: (2025)
Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
par: Chase Peng Yun Ng, et autres
Publié: (2025)
par: Chase Peng Yun Ng, et autres
Publié: (2025)
Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re‐staging TURBT and Intravesical Adjuvant Therapy
par: Tarek Ajami, et autres
Publié: (2024)
par: Tarek Ajami, et autres
Publié: (2024)
Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
par: Thomas Philip Cahill, et autres
Publié: (2024)
par: Thomas Philip Cahill, et autres
Publié: (2024)
Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
par: Makito Miyake, et autres
Publié: (2025)
par: Makito Miyake, et autres
Publié: (2025)
Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
par: Amandeep Arora, et autres
Publié: (2025)
par: Amandeep Arora, et autres
Publié: (2025)
Health utility value of overactive bladder in Japanese older adults
par: Takashi Yoshioka, et autres
Publié: (2024)
par: Takashi Yoshioka, et autres
Publié: (2024)
Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
par: Joshua D. Cabral, et autres
Publié: (2026)
par: Joshua D. Cabral, et autres
Publié: (2026)
Robotic retroperitoneal surgery in a uro‐oncology specialised centre: Translating RPLND expertise from testicular cancer to non‐genitourinary retroperitoneal tumour resection
par: Alberto Costa Silva, et autres
Publié: (2026)
par: Alberto Costa Silva, et autres
Publié: (2026)
Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
par: Austin Drysch, et autres
Publié: (2025)
par: Austin Drysch, et autres
Publié: (2025)
MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
par: Herbert Lepor, et autres
Publié: (2025)
par: Herbert Lepor, et autres
Publié: (2025)
Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery
par: Sezgin Yeni, et autres
Publié: (2025)
par: Sezgin Yeni, et autres
Publié: (2025)
Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
par: Lu Yu Kuo, et autres
Publié: (2025)
par: Lu Yu Kuo, et autres
Publié: (2025)
Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
par: Cameron E. Alexander, et autres
Publié: (2024)
par: Cameron E. Alexander, et autres
Publié: (2024)
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
par: Esther H. J. Hamoen, et autres
Publié: (2025)
par: Esther H. J. Hamoen, et autres
Publié: (2025)
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
par: Kira Furlano, et autres
Publié: (2024)
par: Kira Furlano, et autres
Publié: (2024)
Incidental crossed fused renal ectopia detected during prostate cancer staging: A photorealistic three‐dimensional rendering
par: Kei Ushijima, et autres
Publié: (2025)
par: Kei Ushijima, et autres
Publié: (2025)
Malignant upper urinary tract obstruction in cancer patients: A systematic review
par: Max Shah, et autres
Publié: (2024)
par: Max Shah, et autres
Publié: (2024)
Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
par: Stijn M. van den Bosch, et autres
Publié: (2026)
par: Stijn M. van den Bosch, et autres
Publié: (2026)
Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
par: Jonathon Dawson, et autres
Publié: (2024)
par: Jonathon Dawson, et autres
Publié: (2024)
Documents similaires
-
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
par: Arjun Pon Avudaiappan, et autres
Publié: (2024) -
Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
par: Yin Zhou, et autres
Publié: (2024) -
Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
par: Sean Lim, et autres
Publié: (2026) -
Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
par: Shugo Yajima, et autres
Publié: (2025) -
Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
par: Mohammed Al‐Zubaidi, et autres
Publié: (2024)